Vocal function exercises for normal voice: The effects of varying dosage.


Journal

International journal of speech-language pathology
ISSN: 1754-9515
Titre abrégé: Int J Speech Lang Pathol
Pays: England
ID NLM: 101320232

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 20 9 2017
medline: 31 12 2019
entrez: 20 9 2017
Statut: ppublish

Résumé

This study examined the effect of varying dosage of vocal function exercise (VFE) home practice on attainment of pre-established maximum phonation time (MPT) goals in individuals with normal voice. High dosage VFE practice was expected to result in greatest MPT. The overarching goal of this study was to contribute to a VFE dosage-response curve, potentially including a point of observable toxicity. Twenty-eight females ages 18-25 with normal voice participated in this pre-post longitudinal group study. Participants were randomly assigned to one of three experimental groups and completed a six-week VFE protocol with practice twice daily. The low dosage group performed each exercise once, the traditional group twice, and the high dosage group four times. The primary outcome measure was MPT as performed on the fourth VFE using the prescribed semi-occluded vocal tract posture. No toxic effects were observed. MPT increased for all participants, with significant improvement for traditional and high dosage groups. High dosage VFEs may yield more rapid improvement in MPT, however benefits must be weighed against the risk of increased attrition. Low dosage VFEs insufficiently improved MPT. Further research on dosage is warranted, and should include individuals with disordered voice.

Identifiants

pubmed: 28925286
doi: 10.1080/17549507.2017.1373858
pmc: PMC6207485
mid: NIHMS993813
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-45

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR001997
Pays : United States

Références

Percept Mot Skills. 2011 Jun;112(3):729-36
pubmed: 21853762
J Voice. 2017 Jul;31(4):506.e25-506.e31
pubmed: 27993500
J Voice. 2015 Nov;29(6):718-26
pubmed: 26296853
J Speech Lang Hear Res. 2006 Apr;49(2):448-59
pubmed: 16671856
J Voice. 2017 Mar;31(2):245.e9-245.e14
pubmed: 27595526
Int J Speech Lang Pathol. 2013 Apr;15(2):127-35
pubmed: 22909150
J Voice. 2015 Sep;29(5):638-44
pubmed: 25944293
J Voice. 2016 May;30(3):377.e11-9
pubmed: 25959424
J Voice. 2010 Jul;24(4):470-6
pubmed: 19664899
J Neurophysiol. 1998 Feb;79(2):1117-23
pubmed: 9463469
J Otolaryngol Head Neck Surg. 2009 Apr;38(2):261-78
pubmed: 19442378
J Voice. 2001 Mar;15(1):105-14
pubmed: 12269625
Laryngoscope. 2014 Aug;124(8):1869-76
pubmed: 24375313
J Speech Lang Hear Res. 2015 Jun;58(3):535-49
pubmed: 25675335
J Laryngol Otol. 2009 Feb;123(2):253-6
pubmed: 18384698
Neuron. 2011 Nov 3;72(3):443-54
pubmed: 22078504
Neurology. 1996 Dec;47(6):1496-504
pubmed: 8960734
J Speech Lang Hear Res. 2003 Jun;46(3):670-88
pubmed: 14696994
Int J Speech Lang Pathol. 2012 Oct;14(5):401-9
pubmed: 22916999
Int J Speech Lang Pathol. 2012 Oct;14(5):419-23
pubmed: 22574765
J Voice. 2012 Sep;26(5):672.e19-27
pubmed: 22717496
J Speech Hear Res. 1995 Dec;38(6):1232-51
pubmed: 8747817
Logoped Phoniatr Vocol. 2001;26(1):37-46
pubmed: 11432413
J Voice. 1995 Mar;9(1):27-36
pubmed: 7757147
J Voice. 1994 Sep;8(3):271-8
pubmed: 7987430
Am J Speech Lang Pathol. 2009 May;18(2):124-32
pubmed: 18930908
J Voice. 2008 Jan;22(1):70-4
pubmed: 17070009
J Voice. 2014 Sep;28(5):652.e31-652.e43
pubmed: 24929936
Laryngoscope. 2008 Oct;118(10):1900-3
pubmed: 18622308
J Speech Lang Hear Res. 2001 Apr;44(2):286-96
pubmed: 11324651
J Voice. 2013 May;27(3):321-34
pubmed: 23159032
Laryngoscope. 2007 Apr;117(4):628-33
pubmed: 17429872
Am J Speech Lang Pathol. 2007 May;16(2):95-107
pubmed: 17456888
Logoped Phoniatr Vocol. 2012 Oct;37(3):123-6
pubmed: 22409651
J Voice. 1995 Mar;9(1):74-85
pubmed: 7757153
Ann Otol Rhinol Laryngol. 2010 Jul;119(7):460-7
pubmed: 20734967
Logoped Phoniatr Vocol. 2007;32(3):128-40
pubmed: 17852714
J Voice. 2011 Sep;25(5):562-9
pubmed: 20570107
J Voice. 2006 Sep;20(3):423-31
pubmed: 16293396
J Voice. 1999 Dec;13(4):557-69
pubmed: 10622521
J Voice. 2012 Nov;26(6):734-41
pubmed: 22717492

Auteurs

Maria Bane (M)

a Rehabilitation Sciences Doctoral Programme , University of Kentucky , Lexington , KY , USA.

Vrushali Angadi (V)

a Rehabilitation Sciences Doctoral Programme , University of Kentucky , Lexington , KY , USA.

Emily Dressler (E)

a Rehabilitation Sciences Doctoral Programme , University of Kentucky , Lexington , KY , USA.

Richard Andreatta (R)

a Rehabilitation Sciences Doctoral Programme , University of Kentucky , Lexington , KY , USA.

Joseph Stemple (J)

a Rehabilitation Sciences Doctoral Programme , University of Kentucky , Lexington , KY , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH